Advances in Cellular Characterization of the Sirtuin lsoform, SIRT7

被引:59
|
作者
Wu, Di [1 ,2 ]
Li, Yinglu [3 ]
Zhu, Kathy S. [4 ]
Wang, Haiying [1 ,5 ]
Zhu, Wei-Guo [3 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci,Minist Educ, Key Lab Carcinogenesis & Translat Res,Beijing Key, Beijing, Peoples R China
[2] Peking Univ, Inst Syst Biomed, Sch Basic Med Sci, Hlth Sci Ctr, Beijing, Peoples R China
[3] Shenzhen Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shenzhen, Peoples R China
[4] Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China
[5] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
SIRT7; rDNA transcription; ribosome biogenesis; cellular stress; metabolism; aging; genome stability; cancer; RNA-POLYMERASE I; HEPATOCELLULAR-CARCINOMA; H3K18; DEACETYLATION; STRESS-RESPONSE; DOWN-REGULATION; PROTEIN SIR2; 7; EXPRESSION; INHIBITION; DNA; NUCLEAR;
D O I
10.3389/fendo.2018.00652
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SIRT7 is one of seven mammalian sirtuins that functions as an NAD(+)-dependent histone/protein deacetylase. SIRT7 is the least well-known member of the sirtuin family, but recent efforts have identified its involvement in various cellular processes, such as ribosome biogenesis, gene expression, cellular metabolism and cancer. Here we provide an update on the functions and mechanisms of SIRT7 in cellular regulation and disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Structural basis of SIRT7 nucleosome engagement and substrate specificity
    Moreno-Yruela, Carlos
    Ekundayo, Babatunde E.
    Foteva, Polina N.
    Ni, Dongchun
    Calvino-Sanles, Esther
    Stahlberg, Henning
    Fierz, Beat
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [42] Identification of a novel SIRT7 inhibitor as anticancer drug candidate
    Kim, Ji-Hye
    Kim, Dahee
    Cho, Suk Joon
    Jung, Kwan-Young
    Kim, Jong-Hoon
    Lee, Jun Mi
    Jung, Hee Jung
    Kim, Kwang Rol
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 508 (02) : 451 - 457
  • [43] SIRT7: a novel molecular target for personalized cancer treatment?
    Alessandro Ianni
    Poonam Kumari
    Shahriar Tarighi
    Thomas Braun
    Alejandro Vaquero
    Oncogene, 2024, 43 : 993 - 1006
  • [44] SIRT7: a novel molecular target for personalized cancer treatment?
    Ianni, Alessandro
    Kumari, Poonam
    Tarighi, Shahriar
    Braun, Thomas
    Vaquero, Alejandro
    ONCOGENE, 2024, 43 (14) : 993 - 1006
  • [45] SIRT7 epigenetically regulates MITF to promote melanoma growth
    Guo, W.
    Ma, J.
    Pei, T.
    Wang, S.
    Guo, S.
    Gao, T.
    Li, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S204 - S204
  • [46] The controversial role of Sirtuins in tumorigenesis - SIRT7 joins the debate
    Li, Ling
    Bhatia, Ravi
    CELL RESEARCH, 2013, 23 (01) : 10 - 12
  • [47] Sirt7 Regulates Wound Healing by Modulating TGFβ Signaling
    Araki, Satoshi
    Izumiya, Yasuhiro
    Rokutanda, Taku
    Hanatani, Shinsuke
    Kimura, Yuichi
    Bober, Eva
    Braun, Thomas
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [48] SIRT7 Is an RNA-Activated Protein Lysine Deacylase
    Tong, Zhen
    Wang, Miao
    Wang, Yi
    Kim, David D.
    Grenier, Jennifer K.
    Cao, Ji
    Sadhukhan, Sushabhan
    Hao, Quan
    Lin, Hening
    ACS CHEMICAL BIOLOGY, 2017, 12 (01) : 300 - 310
  • [49] Sirtuins and DNA damage repair: SIRT7 comes to play
    Vazquez, Berta N.
    Thackray, Joshua K.
    Serrano, Lourdes
    NUCLEUS, 2017, 8 (02) : 107 - 115
  • [50] SIRT7 is an important regulator of cartilage homeostasis and osteoarthritis development
    Korogi, Wataru
    Yoshizawa, Tatsuya
    Karim, Md. Fazlul
    Tanoue, Hironori
    Yugami, Masaki
    Sobuz, Shihab U.
    Hinoi, Eiichi
    Sato, Yoshifumi
    Oike, Yuichi
    Mizuta, Hiroshi
    Yamagata, Kazuya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 496 (03) : 891 - 897